Tobakient By Levins Pharma Overview & Drug Interactions

Check For Interactions With Tobakient

Supplement: Tobakient by Levins Pharma

Tobakient Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Tobakient by Levins Pharma

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 30
UPC/BARCODE 371905100301

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin C
200 mg
Vitamin C 222%
Vitamin D3
20 mcg
Vitamin D 100%
Riboflavin
1.7 mg
Riboflavin 131%
Vitamin B6
2 mg
Vitamin B6 118%
Folic Acid
1667 mcg DFE
Folate 417%
L-Glutathione
250 mg
Glutathione --
Astaxanthin
4 mg
Astaxanthin --

Other Ingredients:
Microcrystalline Cellulose
Gelatin
Forms
  • Capsule
Magnesium Stearate
Silica
Titanium Dioxide
FD&C Blue 1


Label Statments:


General Statements
- 71905-0100-30
- For product information peel here
- How Supplied Health Claims: Tobakient capsules are supplied as (blue and white, oblong-shaped) capsules in a child-resistant bottle of 30 count ("71905-0100-30").
- Levins Pharmaceuticals does not represent these product codes to be National Drug Codes (NDC). Product codes are formatted according to standard industry practice, to meet the formatting requirement by pedigree reporting and supply-chain control including pharmacies.
- 1. Federal Register Notice of August 2, 1973 (38 FR 20750) 2. Federal Register Notice of October 17, 1980 (45 FR 69043, 69044) 3. Federal Register Notice of March 5, 1996 (61 FR 8760)
FDA Statement of Identity
- Dietary Supplement
Formulation
- Dispensed by prescription
- Tobakient is an orally administered prescription vitamin formulation for the clinical dietary management of suboptimal nutritional status in patients experiencing physiologically stressful conditions such as use of tobacco products, or to maintain levels when dietary intake of vitamins is inadequate or excretion or loss is excessive.
Suggested/Recommended/Usage/Directions
- Dosage and Administration: Usual adult dose is one (1) capsule once or twice daily or as prescribed by a licensed medical practitioner.
Precautions
- Keep out of reach of children
- Health Claim Tobakient capsules dietary supplement dispensed by prescription This product is a prescription- folic acid with or without other dietary ingredients that – due to increased folic acid levels increased risk associated with masking of B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760). The most appropriate way to ensure pedigree reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription (Rx). This is not an Orange Book product.
- Warning and Precautions: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
- Tobakient capsules should only be used under the direction and supervision of a licensed medical practitioner.
- Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.
- Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.
- This product may be administered only under a physician's supervision and all prescriptions using this product shall be pursuant to state statutes as applicable. The ingredients, indication or claims of this product are not to be construed to be drug claims.
- Tamper Evident: Do not use if seal is broken or missing. To report adverse events or to obtain product information, contact 228-392-0043.
Storage
- Storage and Handling: Store as 20 degrees-25 degrees C (68 degrees-77 degrees F); excursions permitted to 15 degrees-30 degrees C (59 degrees-86 degrees F) [See USP Controlled Room Temperature.] Protect from heat, light, and moisture
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Brand IP Statement(s)
- Setria is a registered trademark of KYOWA HAKKO CIO Co., Ltd. AstraReal is a trademark of Fuji Chemical Industry, Co., Ltd.

Brand Information

See all products by this brand

Manufactured for
Name Levins Pharmaceuticals, LLC
Street Address 15121 Lemoyne Blvd
City Biloxi
State MS
ZipCode 39532
Phone Number 228-392-0043

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.